Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/10851
Title: Fenfluramine augmentation of clomipramine treatment of obsessive compulsive disorder.
Austin Authors: Judd, F K;Chua, P;Lynch, C;Norman, Trevor R 
Affiliation: University of Melbourne, Department of Psychiatry, Austin Hospital, Heidelberg, Vic.
Issue Date: 1-Sep-1991
Publication information: The Australian and New Zealand Journal of Psychiatry; 25(3): 412-4
Abstract: Recently, much research interest has been directed to demonstrating a possible biological basis to obsessive compulsive disorder. In particular, dysregulation in brain serotonin is suggested to be important. Two cases are described in which fenfluramine, a presynaptic 5 HT-releasing agent and 5HT-reuptake inhibitor was used to augment clomipramine treatment for OCD.
Gov't Doc #: 1958165
URI: https://ahro.austin.org.au/austinjspui/handle/1/10851
Journal: The Australian and New Zealand Journal of Psychiatry
URL: https://pubmed.ncbi.nlm.nih.gov/1958165
Type: Journal Article
Subjects: Adult
Clomipramine.administration & dosage
Dose-Response Relationship, Drug
Drug Administration Schedule
Drug Therapy, Combination
Female
Fenfluramine.administration & dosage
Humans
Obsessive-Compulsive Disorder.psychology.therapy
Appears in Collections:Journal articles

Show full item record

Page view(s)

18
checked on Apr 20, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.